AI assistant
Sending…
GYRE THERAPEUTICS, INC. — Director's Dealing 2014
Oct 21, 2014
32556_dirs_2014-10-21_57a5e6a7-b9c6-448b-b686-6e1b0735028d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TARGACEPT INC (TRGT)
CIK: 0001124105
Period of Report: 2014-10-17
Reporting Person: Musso Alan A (SVP, Fin+Admin, CFO & Treas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-17 | Common Stock | A | 55000 | — | Acquired | 57799 | Direct |
Footnotes
F1: This restricted stock award vests in two equal, annual installments beginning on December 31, 2015 and becomes vested in full on December 31, 2016.
More from GYRE THERAPEUTICS, INC.
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Regulatory Filings
2026
Jan 5